ÀûÀ´¹ú¹ú¼ÊÀÏÅÆ

EN
EN
  • ÒµÎñ×Éѯ

    Öйú£º

    Email: marketing@medicilon.com.cn

    ÒµÎñ×ÉѯרÏߣº400-780-8018

    £¨½öÏÞ·þÎñ×Éѯ£¬ÆäËûÊÂÒËÇ벦´ò´¨É³×ܲ¿µç»°£©

    ´¨É³×ܲ¿µç»°: +86 (21) 5859-1500

    º£Í⣺

    +1(781)535-1428(U.S.)

    0044 7790 816 954 (Europe)

    Email:marketing@medicilon.com

ÔÚÏßÁôÑÔ¡Á
µã»÷Çл»
FAQs

ÔÚÎÒ¹úÉ걨INDÇ°Ó¦¸ÃÍê³ÉÄÄЩIn VitroµÄPKÊÔÑ飿

£¨1£©Ñª½¬µ°°×½áºÏÊÔÑ飨PPB£©£ºÔÚ2014°æ¡¶ÁÙ´²Ç°Ò©´úÖ¸µ¼Ô­Ôò¡·ÖÐÓÐÃ÷È·¹æ¶¨£¬ÊÔÑéÉè¼ÆÖÐN=3£¬ÐèÒª¹ØעŨ¶ÈÒÀÀµÐÔºÍÖÖÊô²îÒ죻

£¨2£©ÌåÍâ´úл£¨Metabolic  stability/MetID£©£º¹Ø×¢ÖÖÊô²îÒ죬ΪÌåÄÚPK¼°¶¾Àí¡¢ÖÖÊôµÄÑ¡ÔñÌṩ²Î¿¼£»

£¨3£©ÌåÍâDDI£ºP450ÒÖÖÆ£¬P450ÓÕµ¼£¨Êý¾Ý·ÖÎö²Î¿¼FDA  Guidance£ºDDI 2006 DraftºÍ2020 In Vitro DDI£©£¬Ã¸±íÐÍCYP/Non-CYP´úл;¾¶¼ø¶¨£»

£¨4£©×ªÔËÌåÑо¿£¨Transporter  substrate assessment & inhibition£©£ºCaco-2, P-gp, BCRP,  OATP1B1, OATP1B3, OAT1, OAT3, OCT2¡£

¡Á
ËÑË÷ÑéÖ¤
µã»÷Çл»
sitemap¡¢ÍøÕ¾µØͼ